Bio Pharma Dive

OCTOBER 28, 2021

In a move that surprised Wall Street analysts, the executive, who has overseen Alnylam's journey from startup to one of biotech's top companies, will leave by the end of the year for an unspecified role "helping other entrepreneurs."

287

287

Pharmaceutical Technology

NOVEMBER 8, 2023

The executive order highlights the US sentiment towards AI regulation, but presents a fragmented approach with possibility of discord.

Regulation 130

Regulation 130

Bio Pharma Dive

FEBRUARY 1, 2024

François-Xavier Roger will replace current CFO Jean-Baptiste Chasseloup de Chatillon as Sanofi continues a research pivot and cost-cutting drive.

Research 265

Research 265

Pharma Mirror

SEPTEMBER 9, 2022

(STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board Director.

RNA 130

RNA Development 130

Pharma Mirror

OCTOBER 17, 2022

BRISBANE, AUS, AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, announced today new senior executive hires to support global growth plans. Dr. Haifer stated “These.

HR 130

HR Protein Vaccination Vaccine 130

Bio Pharma Dive

APRIL 17, 2024

The venture firm has brought in as venture partner Uwe Schoenbeck, who most recently was the top scientist for Pfizer’s emerging science and innovation unit.

Scientist 156

Scientist 156

Bio Pharma Dive

SEPTEMBER 6, 2023

Jane Grogan, an industry veteran who worked at Genentech for over 15 years, will take over the role starting Oct. She’ll fill a seat that's lacked a permanent replacement since the departure of Al Sandrock.

Research 293

Research 293

Pharmaceutical Technology

JANUARY 5, 2023

III (ALPA) has executed a definitive merger agreement with Phase II-stage biotechnology platform company Carmell Therapeutics. The post ALPA executes merger agreement with Carmell Therapeutics appeared first on Pharmaceutical Technology. Alpha Healthcare Acquisition Corp.

Production 130

Production Marketing Development 130

Antidote

DECEMBER 22, 2023

One patient we’ve had the pleasure of speaking with is Linda VandeVrede, a former high-tech PR executive who shared her story of chronic pain, clinical trials, and personal experience. Because Antidote’s key focus is connecting patients to clinical trials , hearing directly from individuals serves as a great reminder of why we do what we do.

Clinical Trials 114

Clinical Trials Clinical Trials Trials 114

Bio Pharma Dive

SEPTEMBER 27, 2023

John Tsai, previously Novartis’ chief medical officer, has been named CEO of Forcefield Therapeutics, an 18-month-old biotech working on a treatment for heart attacks.

Drugs 272

Drugs 272

BioSpace

OCTOBER 31, 2023

Here’s how expanding companies can benefit from executive-level strategic experience in key areas while staying lean and nimble.

115

115

Bio Pharma Dive

JANUARY 4, 2024

Moonwalk Biosciences, the latest biotech cofounded by the gene editing scientist, joins other startups aiming to alter gene expression without changing DNA.

Gene Editing 349

Gene Editing Gene Expression DNA Gene 349

Bio Pharma Dive

AUGUST 31, 2023

Houman Ashrafian, currently a scientific advisor at SV Health Investors, will fill the role left by John Reed, who oversaw the transformation of research and development during his five years at Sanofi.

Development 287

Development Research 287

Bio Pharma Dive

APRIL 4, 2022

The Swiss pharma said its plan to merge multiple business units and cut yearly costs by $1 billion is likely to impact jobs, but declined to specify which roles and how many.

294

294

Scienmag

DECEMBER 8, 2021

Toronto – Executive development programs have entered a period of rapid transformation, driven by digital disruption and a widening gap between the skills that participants and their organizations demand and those provided by their executive programs.

Development 83

Development 83

NPR Health - Shots

NOVEMBER 16, 2022

NPR spoke with 26 people who were involved with more than 200 executions across the country. Most said their health suffered and they had little support to help them cope with their unusual jobs. Image credit: Sean Rayford, Emily Najera, Celeste Noche, Scott Langley and Octavio Jones for NPR)

145

145

Roots Analysis

AUGUST 14, 2023

Manufacturing execution systems (MES) play a crucial role in achieving long term competitive advantages in the healthcare industry. In recent years, several healthcare stakeholders have actively undertaken initiatives to incorporate manufacturing execution system into their production lines.

Manufacturing 52

Manufacturing Production Packaging Packaging 52

CTTI (Clinical Trials Transformation Initiative)

OCTOBER 17, 2023

Both Hanger and Okun are working with Executive Committee leadership – Chair Mark McClellan, Duke Co-chair John Alexander, and FDA Co-chair Khair ElZarrad – on a thoughtful succession plan that ensures the highest level of team and organizational integrity. 

Clinical Trials 75

Clinical Trials Clinical Trials Trials Life Science 75

BioSpace

MARCH 26, 2024

Bayer cut its C-suite nearly in half amid a massive restructuring. Meanwhile, the U.S. government says it will pay for Wegovy for patients with heart disease.

108

108

BioSpace

NOVEMBER 16, 2022

According to a BIO report, less than a third of executive team members are women. BioSpace spoke with three influential women in biopharma to get their advice on breaking the executive barrier.

101

101

Bio Pharma Dive

JANUARY 19, 2023

“What we’re experiencing now is the aftershock of the party that went on for the last three years,” said Ovid CEO Jeremy Levin in a BioPharma Dive panel that included former Sage head Jeff Jonas and biotech entrepreneur Greg Verdine.

Marketing 331

Marketing Drugs 331

Bio Pharma Dive

JUNE 2, 2022

Severino left the pharma company in April after eight years as its chief scientist and then president. He'll lead Tessera Therapeutics, a well-funded genetic medicine startup.

Pharma Companies 265

Pharma Companies Genetics Scientist Medicine 265

Bio Pharma Dive

JUNE 4, 2021

Marc Dunoyer, the U.K. drugmaker's longtime finance chief, will move over to a strategy role and run Alexion as a rare disease unit within AstraZeneca.

289

289

Bio Pharma Dive

JULY 18, 2022

Baisong Mei, a veteran of Sanofi and Biogen, comes to Editas half a year after the gene editing company fired his predecessor and one month after new CEO Gilmore O'Neill started on the job.

Gene Editing 272

Gene Editing Gene 272

Bio Pharma Dive

FEBRUARY 8, 2023

Anderson, who stepped down as Roche's pharmaceuticals chief in December, will replace Bayer's current head Werner Baumann on June 1.

235

235

Bio Pharma Dive

SEPTEMBER 11, 2023

Bill Sibold has led Sanofi's specialty care business unit for the past six years. He replaces Paul Friedman as head of the NASH drug developer.

Development 156

Development Drugs 156

Roots Analysis

AUGUST 9, 2023

It is worth mentioning that in recent years, several healthcare stakeholders have actively undertaken initiatives to incorporate a manufacturing execution system (MES) into their production lines, with an aim to connect, monitor and control the complex manufacturing process. Below, I have pasted figure that depicts our proprietary framework.

Manufacturing 52

Manufacturing Production Marketing 52

BioSpace

MARCH 14, 2023

How Executive Pay Packages are Negotiated 3/15/2023

Packaging 98

Packaging Packaging 98

STAT News

MARCH 28, 2023

The tech-forward insurer Oscar Health has tapped former Aetna CEO Mark Bertolini to be its new chief executive, a move to jump-start the business as it seeks to win new customers and become profitable.

98

98

Bio Pharma Dive

FEBRUARY 25, 2021

Tal Zaks, the biotech's chief medical officer for the past six years, will depart in September after playing a high-profile role in the company's coronavirus vaccine development.

Vaccination 303

Vaccination Vaccine Development 303

Pharma Mirror

APRIL 28, 2021

Ahead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma survey[i] predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally.

Manufacturing 130

Manufacturing 130

Bio Pharma Dive

APRIL 14, 2022

A little more than a year after taking on the role, Jim Mullen is preparing to pass the torch to Gilmore O'Neill, who has served as the chief medical officer at Sarepta Therapeutics.

256

256

Bio Pharma Dive

FEBRUARY 8, 2021

James Mullen, chair of Editas' board and a former Biogen CEO, will replace Cynthia Collins in a critical year for the gene editing biotech.

Gene Editing 306

Gene Editing Gene 306

Bio Pharma Dive

AUGUST 17, 2022

The COVID-19 vaccine maker has appointed James Mock, currently PerkinElmer’s CFO, as its next finance head, three months after ousting Jorge Gomez from the role.

Vaccination 251

Vaccination Vaccine 251

Bio Pharma Dive

JULY 22, 2021

The company responded forcefully to controversy roiling around the Alzheimer's drug's approval, defending its data and interactions with the FDA.

Drugs 256

Drugs 256

Scienmag

MAY 26, 2022

Boyce Thompson Institute (BTI) is pleased to welcome Sheila Ochugboju as the new Executive Director of the Alliance for Science (AfS), a global communications initiative dedicated to promoting access to scientific innovation as a means of enhancing food security, improving environmental sustainability, and raising the quality of life globally.

80

80